Leadership Team at CZI, Biohub and Learning Commons

Priscilla Chan is the co-founder and co-CEO of the Chan Zuckerberg Initiative, where she leads efforts to advance biomedical research and technology to help scientists cure, prevent, or manage all disease by the end of this century. As a pediatrician, her firsthand experience caring for patients has fueled her commitment to accelerating scientific discovery. Priscilla’s leadership at CZI has focused on harnessing AI, building cutting-edge research tools, and funding innovative science to unlock new insights into human biology. She earned her bachelor's degree in biology from Harvard University and her doctor of medicine from the University of California, San Francisco, where she also completed her pediatrics residency.
Mark Zuckerberg is co-founder and co-CEO of the Chan Zuckerberg Initiative, where he brings deep technical expertise and experience building communities to inform the organization’s work. Mark is also the founder and CEO of Meta, where he leads the development of the company's products and technology. He studied computer science at Harvard University before moving to Palo Alto, California, in 2004.
Lori Goler is president of the Chan Zuckerberg Initiative, where she oversees CZI’s work in science and education, leads the organization's operations and empowers teams to deliver with purpose and impact. She previously served as chief people officer at Meta, overseeing the company’s global people strategy and operations over a 16-year period during which Meta scaled from approximately 500 people to more than 80,000 people and was consistently celebrated as one of the best places to work. Earlier in her career, she was General Manager of eBay Stores, a founding executive at eStyle, and held business planning roles at The Walt Disney Company. Lori served on the Board of Directors of Stanford Health Care for nearly a decade, gaining firsthand insight into the power of science and technology to improve lives. She holds a bachelor’s degree from Yale University, an MBA from Harvard Business School, and a master’s in public policy from Harvard’s Kennedy School of Government.
Ben Roh is the chief operating officer and chief financial officer for the Chan Zuckerberg Initiative where he oversees core operational teams. Ben has been with the organization since 2017, helping to build our initial financial and operational foundation. Ben was previously the CFO/COO at Gradient Learning, and before that, he held leadership roles at various tech companies ranging from early-stage to Fortune 100 organizations. Ben received his undergraduate degree in business from the University of Washington.
Mark Kim is the general counsel for the Chan Zuckerberg Initiative. Before joining CZI, Mark was a partner at Munger, Tolles & Olson (MTO), where he practiced corporate law, with a focus on mergers and acquisitions, joint ventures and corporate governance. While at MTO, Mark played an integral role in the structuring and establishment of both CZI and Biohub and represented CZI and Biohub as lead outside counsel. Mark received his law degree from Yale Law School, where he served as a student director for the Advocacy for Parents and Children legal clinic, and received his undergraduate degree from Harvard College. Following law school, Mark clerked for Judge Pamela Ann Rymer on the United States Court of Appeals for the Ninth Circuit.
As the Chan Zuckerberg Initiative’s chief investment officer, David Lee is responsible for managing CZI’s investment portfolio, which funds the organization’s efforts across science, education, and within our communities. David came to CZI from the Princeton University Investment Company, where he worked on asset allocation and the marketable asset categories, including domestic equity, international equity and independent return. Prior to Princeton, David worked at ABN AMRO in London, England. He earned a first-class honors degree in economics and econometrics from the University of York, holds a Master of Science with distinction specializing in quantitative finance from the University of Reading, and received an MBA from the Yale School of Management. He is a CFA Institute charterholder.
Alex Rives is head of science at the Chan Zuckerberg Initiative, leading its work at the intersection of artificial intelligence and biology through Biohub. Alex was a founder and chief scientist at EvolutionaryScale, a public-benefit company developing AI to accelerate scientific discovery in biology, and delivering transformative AI systems and applications to benefit the global scientific community. He is a Core Institute Member at the Broad Institute and Assistant Professor in EECS at MIT. Alex was honored as part of the 2026 TIME100 AI list, recognizing him among the world’s most influential people shaping artificial intelligence. As a scientist, Rives has done pioneering work in artificial intelligence for biology. He started and led the Evolutionary Scale Modeling, or ESM, project at Meta’s fundamental AI research lab, which developed the first large scale transformer language models for proteins. The ESM models are widely recognized as a breakthrough in artificial intelligence for biology, and opened the field of language modeling in biology. These models are used by scientists worldwide, enabling applications including designing therapeutic proteins such as antibodies, predicting the effects of mutations in the human genome, illuminating evolutionary history, discovering new proteins, and creating models of the cell. Rives earned a bachelor’s degree in philosophy and biology from Yale University and a doctorate in computer science from New York University.
Patricia Brennan serves as vice president, technology and general manager, science. Previously, Patricia held leadership roles at Clarivate and Thomson Reuters, where she led product design, product management and platform development. She is also a product coach and advisor to individuals and organizations, where she assists t